Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

    Stock Recap
    #PipelineProspector

    Menu

    Nitarsone

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Holder VMF No. Subject Received Date Status Type
    27/02/2026 Zhejiang Rongyao Biotech
    China
    		 ZHEJIANG RONGYAO BIOTECH CO LTD 5849 Nitarsone 2005-11-03 Active II
    27/02/2026 ZHEJIANG HUANGYAN RONGYAO CHEMICAL FACTORY 5546 Nitarsone 1995-09-15 Inactive II
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.